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Long-Term Prognosis of Brugada-Type ECG and ECG With Atypical
ST-Segment Elevation in the Right Precordial Leads Over 20 Years:
Results From the Circulatory Risk in Communities Study (CIRCS)
Hidekazu Tsuneoka, MD, PhD;* Masahiko Takagi, MD, PhD;* Nobuyuki Murakoshi, MD, PhD; Kazumasa Yamagishi, MD, PhD;
Yasuhiro Yokoyama, MD, PhD; DongZhu Xu, MD, PhD; Yukio Sekiguchi, MD, PhD; Hiro Yamasaki, MD, PhD; Yoshihisa Naruse, MD, PhD;
Yoko Ito, MD, PhD; Miyako Igarashi, MD, PhD; Akihiko Kitamura, MD, PhD; Takeo Okada, MD, PhD; Takeshi Tanigawa, MD, PhD;
Keisuke Kuga, MD, PhD; Tetsuya Ohira, MD, PhD; Hiroshi Tada, MD, PhD; Kazutaka Aonuma, MD, PhD; Hiroyasu Iso, MD, PhD; for the
CIRCS Investigators†
Background-—Brugada syndrome is recognized as being associated with sudden cardiac death; however, the prevalence of non–
type 1 Brugada-type ECG (BrS) or atypical ST-segment elevation in the right precordial leads (STERP) and the long-term prognosis
for those patients remain unknown.
Methods and Results-—We analyzed standard 12-lead ECGs of 7178 apparently healthy participants (age range 40–64 years) who
underwent health checkups from 1982 to 1986 in the Circulatory Risk in Communities Study, a prospective, large, community-
based cohort study in Japan. ECGs with J point amplitude ≥0.2 mV in the right precordial leads were divided into 3 groups: (1) type
1 BrS, (2) type 2 or 3 BrS (non-type 1 BrS), and (3) STERP. The others served as the non–ST-segment elevation group. We identiﬁed
8 participants (0.1%) with type1 BrS, 84 (1.2%) with non–type 1 BrS, and 228 (3.2%) with STERP. During a median follow-up of
18.7 years (133 987.0 person-years), sudden cardiac death was observed in no participants (0.0%) with type 1 BrS, in 1 (1.2%)
with non–type 1 BrS, in 7 (3.1%) with STERP, and in 50 (0.7%) with non–ST-segment elevation. Participants with STERP had a
markedly elevated risk of sudden cardiac death (multivariable hazard ratio 3.9, 95% CI 1.7–9.0).
Conclusions-—STERP was associated with an elevated risk of sudden cardiac death in a middle-aged population. ( J Am Heart
Assoc. 2016;5:e002899 doi: 10.1161/JAHA.115.002899)
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B rugada syndrome is a hereditary arrhythmogenic diseasecharacterized by accentuated ST-segment elevation
(type 1) in the right precordial leads (V1 through V3) and
increased risk of sudden cardiac death (SCD) without
structural heart disease.1–3 The data from previous studies
vary regarding prevalence and prognosis for patients with
Brugada-type ECG (BrS) because of different populations (eg,
general population, ofﬁce workers),4–9 different ECG
deﬁnitions,5,6,9–12 relatively short-term follow-up,5,6,9,10,12,13
or poorly deﬁned SCD.5–8,10,11,13,14
The prevalence of non–type 1 BrS and ECGs with a J point
amplitude ≥0.2 mV and non–Brugada-type right precordial ST-
segment (atypical ST-segment elevation in the right precordial
leads [STERP]) and the long-term prognosis for these patients
have not been reported in a prospective community-based
cohort study. Recently, Kamakura et al reported that early
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repolarization (ER) characterized by notching or slurring in the
right precordial leads had a poor prognosis in their hospital-
based study.15 It is difﬁcult, however, to evaluate the J point
morphology because the ST-segment attenuates it; therefore,
we also focused on the J point amplitude in STERP. This study
aimed to use the data from a study with >20 years of follow-
up of 7178 participants in 3 Japanese populations to
investigate the relationship between BrS or ECGs with STERP
and the risk of SCD.
Methods
Study Population
The study included community residents aged 40 to 64 years
who enrolled in a community-based cohort of the Circulatory
Risk in Community Study (CIRCS). CIRCS is a prospective
community-based study that was launched to examine risk
factors of cardiovascular disease from 1963 onward and that
is conducted by a research team from Osaka Medical Center
for Health Science and Promotion, Osaka University, and the
University of Tsukuba. The CIRCS participants lived in Ikawa
town, Akita Prefecture (a northeastern rural community);
Kyowa town, Ibaraki Prefecture (a central rural community);
and Yao City, Osaka Prefecture (a southwestern suburb).
Among them, we recruited 10 337 participants (4223 men,
6114 women) who underwent a health checkup from 1982 to
1986. We excluded 3159 participants who met the following
exclusion criteria: age <40 or >64 years, no previous ECGs on
record, and a past history of myocardial infarction and/or
atrial ﬁbrillation at registration (Figure 1). Systematic com-
munity surveillance of SCD was done for 7178 people (2886
men, 4292 women) who constituted the participants of this
study. The population numbers in each community were 1780
in Ikawa (779 men, 1001 women), 3343 in Kyowa (1431 men,
1912 women), and 2055 in Yao (676 men, 1379 women).
Informed consent was not obtained from the participants but
was obtained from the community representatives to conduct
an epidemiological study based on the guidelines of the
Council for International Organizations of Medical Science.
The study was approved by the ethics committees of Ibaraki
Prefecture, University of Tsukuba, Osaka University, and
Osaka Medical Center for Health Science and Promotion.
Baseline Examinations
Risk factors possibly predisposing to cardiovascular disease
were recorded at participant registration. Hypertension was
deﬁned as systolic blood pressure (BP) ≥140 mm Hg or
diastolic BP ≥90 mm Hg or use of antihypertensive medica-
tions. Arterial BP was measured by trained observers using
standard mercury sphygmomanometers on the right arm of
the seated participants after a 5-minute rest.16 Diabetes
mellitus was deﬁned as a fasting glucose level of ≥126 mg/dL,
a nonfasting glucose level of ≥200 mg/dL, or use of glucose-
lowering medication. Smoking was deﬁned as only current
smoking. Alcohol use was deﬁned as only current use. Height
in stocking feet and weight in light clothing were measured.
Body mass index was calculated as weight (in kg) divided by
the square of height in meters.
ECG Analysis
ECG recordings were performed for all participants every year;
however, not all participants regularly underwent a health
checkup. To make our study as unbiased as possible, we
analyzed only the ﬁrst ECG that was recorded when partic-
ipants were aged 40 to 64 years. At baseline, resting standard
12-lead ECGs were recorded at a paper speed of 25 mm/s in
the supine position and were coded according to the
Minnesota Code by epidemiologist-physicians.17 From a panel
of 4 cardiologists (Y.Y., N.M., Y.S., H.T.) blinded to the data of
risk factor surveys and prognosis, 2 cardiologists indepen-
dently reviewed the baseline ECGs in paper format without
using magniﬁers or other tools. In cases of disagreement as to
the category, a third cardiologist from the panel determined it.
The types of BrSwere classiﬁed according to the ECG criteria
described in the report of the second consensus conference,
which deﬁned type 1 as characterized by a coved-type J point
elevation ≥2 mm (0.2 mV) and non–type 1 as characterized by
type 2 or 3 BrS ECG, that is, a saddleback-type J point elevation
≥2 mm (0.2 mV).3 Patients who had ECGswith J point elevation
≥0.2 mV in the right precordial leads and non-BrS ECG were
categorized as having STERP. Other ECGs were classiﬁed as
non–ST-segment elevation (non-ST). Consequently, ECGs in
this study were categorized into 4 groups: type1 BrS (Fig-
ure 2A), non–type 1 BrS (Figure 2B and 2C), STERP (Figure 2D
and 2E), and non-ST (Figure 2F).
We excluded ECGs with an epsilon wave, which is charac-
teristic of arrhythmogenic right ventricular cardiomyopathy.
The epsilon wave is deﬁned as distinct waves of small amplitude
that occupy the early phase of the ST-segment in the right
precordial leads and that are distinct from the QRS complex.
To examine the association of J point amplitude with SCD
in non-BrS, we excluded participants with type 1 or non–type
1 BrS and divided ECGs for participants without BrS according
to J point amplitude into STERP (group A), ECGs with J point
amplitude ≥0.1 to <0.2 mV (group B), and ECGs with J point
amplitude <0.1 mV (group C).
Follow-up
The participants were followed until the end of 2004. Follow-
up was censored at the date the participant moved out of the
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area or the date of all-cause death. A total of 1206
participants (16.8%) died during the follow-up period.
SCD was deﬁned as a sudden unexpected death either
within 1 hour of symptom onset (for witnessed events) or
within 24 hours of having been observed alive and symptom
free. Cases were excluded if death occurred >24 hours
following the onset of symptoms or if the apparent cause of
death was found to be something other than SCD, such as
cerebrovascular disease, cancer, or accidental death. For all
residents, SCD was determined from death certiﬁcates;
national insurance claims; reports by local physicians, public
health nurses, and health volunteers; and annual cardiovas-
cular risk surveys. To conﬁrm the diagnosis, all living
participants were either telephoned or visited to obtain their
medical history in addition to review of their medical records
including monitor ECGs or 12-lead ECGs not only in the
hospital but also in the ambulance. For deaths, we obtained
histories from families and reviewed medical records to
investigate the mode of onset such as physical activity or
symptoms. A panel of trained epidemiologist-physicians who
were blinded to the data of cardiovascular risk factors made
the ﬁnal diagnosis of SCD. We also excluded participants with
coronary artery disease. The indication of deﬁnite myocardial
infarction was typical severe chest pain accompanied by new,
abnormal, and persistent Q or QS waves or consistent
changes in cardiac enzyme levels. Patients who reported
typical chest pain but whose ECGs and enzyme levels were
nondiagnostic or unattainable were diagnosed as having
possible myocardial infarction.18
Statistical Analysis
Continuous variables are expressed as meanSD, and
categorical variables are presented as percentages. ANCOVA
or the chi-square test was used to test differences in age-
adjusted means and proportions of baseline characteristics by
7178 apparently healthy participants (2886 men and 
4292 women) were followed up through 2004
Excluded (n=3096)
10 337 participants
(4223 men and 6114 women) 
enrolling in CIRCS
40 – 64 years old
No
Yes
ECGs were recorded 
and stored
No
No
Yes
Atrial fibrillation
on ECG tracing Excluded (n=36)
Yes
Excluded (n=14)
Past history of 
myocardial infarction
Yes
No
Excluded (n=13)
Figure 1. Flowchart of the entry process for the 7178 participants.
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the ECG categories. Corrections for multiple comparisons
were made according to the Dunnet method. The chi-square
test was used to perform a frequency comparison. Person-
years were calculated as the sum of individual follow-up times
until participants moved out of the communities, the occur-
rence of all-cause death, or the end of 2004. Hazard ratios
(HRs) and 95% CIs for (1) type 1 BrS, non–type 1 BrS, and
STERP groups against the non-ST group and (2) STERP (J point
amplitude >0.2 mV) and the group with J point amplitude >0.1
to <0.2 mV against the group with J point amplitude <0.1 mV
for SCD were calculated with a Cox proportional hazards
regression model. We adjusted for age (years) and sex and for
V1
V2
V3
A B C D
200 ms
1 mV
E
J point amplitude = 0.6 mV 0.25 mV 0.15 mV 0.18 mV 0.18 mV
J point amplitude = 0.6 mV 0.3 mV 0.3 mV 0.2 mV 0.35 mV
J point amplitude = 0.1 mV 0.2 mV 0.1 mV 0.3 mV 0.25 mV
F
Figure 2. Representative ECG tracings of the type 1 Brugada-type ECG (BrS), non–type 1 BrS, atypical ST-segment elevation in the right
precordial leads (STERP), and non–ST-segment elevation (non-ST) groups. Type 1 BrS (A) is characterized by prominent coved ST-segment
elevation displaying a J point amplitude ≥0.2 mV at its peak, followed by a negative T wave. Non–type 1 BrS (B and C) also has high takeoff ST-
segment elevation, but in this case, the J point amplitude (≥0.2 mV) gives rise to a gradually descending ST-segment elevation followed by a
positive or biphasic T wave that results in a saddleback conﬁguration. STERP (D and E) shows noncoved and nonsaddleback ST-T morphology
with J point elevation ≥0.2 mV in the right precordial leads. F, J point elevation of <0.2 mV in the right precordial leads is included in the non-ST
group.
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other potential confounding variables including systolic BP
(mm Hg), antihypertensive medication use (yes or no),
smoking status (never, former, and current smoker), and
diabetes mellitus (yes or no). Two-tailed testing was per-
formed, and a P<0.05 was considered to indicate signiﬁcance.
All analyses were made with the SAS statistical software
package (version 9.2; SAS Institute).
Results
Prevalence and Clinical Characteristics of Type 1
BrS, Non–Type 1 BrS, and STERP
The prevalence of type 1 BrS, non–type 1 BrS, and STERP of
the 7178 participants was 0.1% (n=8), 1.2% (n=84), and 3.2%
(n=228), respectively. No ECGs with epsilon waves or
markedly prolonged QT intervals were observed. Baseline
characteristics are listed in Table 1. The median follow-up
period was 18.7 years and was uniform among the 4 groups.
Compared with the non-ST group, participants in the other 3
groups showed male predominance, and those with non–type
1 BrS were older, had lower mean body mass index values,
and included a higher proportion of current alcohol use and
smoking. Those with STERP were younger; had lower mean
values for heart rate, diastolic BP, and serum cholesterol; and
included a higher proportion of current alcohol use and
smoking. Those with type 1 BrS had a higher proportion of
current alcohol use. There were no signiﬁcant differences in
mean systolic BP and triglyceride levels or in the prevalence of
hypertension and diabetes mellitus among the 4 groups.
Prognosis of Type 1 BrS, Non–Type 1 BrS, and
STERP
There were 58 SCDs (0.8%) and 1206 all-cause deaths (16.8%)
during the median follow-up of 18.7 years (133 987.0 person-
years). The number of SCDs in the type 1 BrS, non–type 1 BrS,
and STERP groups was 0 (0.0%), 1 (1.2%), and 7 (3.1%),
respectively. Participants with STERP had a markedly elevated
risk of SCD (age- and sex-adjusted HR 4.1, 95% CI 1.8–9.6;
Table 1. Baseline Characteristics and Outcomes of the Type 1 BrS, Non–Type 1 BrS, STERP, and Non-ST Groups
All Participants Type 1 BrS Non–Type 1 BrS STERP Non-ST P Value
Number of participants 7178 8 (0.1) 84 (1.2) 228 (3.2) 6858 (95.5)
Follow-up period, y 18.70.1 17.45.9 17.75.4 18.44.2 18.74.9 0.233
Age, y 51.87.1 52.97.3 54.76.9* 50.37.1* 51.87.1 <0.001
Male 2886 (40.2) 7 (87.5) 74 (88.1) 216 (94.7) 2589 (37.8) <0.001
Height, cm 152.621.3 158.46.3 159.77.4* 161.312.6* 152.221.6 <0.001
Weight, kg 55.311.6 56.56.6 55.67.2 59.98.8* 55.111.7 <0.001
Body mass index, kg/m2 23.43.1 22.51.7 21.82.7* 22.92.4 23.43.2 <0.001
Systolic BP, mm Hg 132.018.5 129.318.5 131.121.9 134.420.0 131.918.4 0.235
Diastolic BP, mm Hg 80.111.4 72.510.7 81.012.0 81.912.7* 80.111.3 0.017
Hypertensive 2552 (35.6) 2 (25.0) 33 (39.3) 97 (42.5) 2420 (35.3) 0.113
Serum total cholesterol, mmol/L 182.736.2 189.339.4 184.033.7 185.737.4* 193.036.1 0.003
Triglycerides, mg/dL 140.9101.6 126.4106.0 123.874.3 143.398.4 147.1102.0 0.568
Current alcohol use 2291 (31.9) 5 (62.5)* 55 (65.5)* 172 (75.4)* 2059 (30.0) <0.001
Current smoking 2217 (30.9) 5 (62.5) 55 (65.5)* 155 (68.0)* 2002 (29.2) <0.001
Diabetes mellitus 312 (4.3) 1 (12.5) 1 (1.2) 14 (6.1) 296 (4.3) 0.167
ECG findings
Heart rate, bpm 68.611.8 64.914.4 65.99.1 64.48.9* 68.811.9 <0.001
QRS axis
Left axial deviation 130 (1.8) 1 (12.5) 4 (4.8) 2 (0.9) 123 (1.8) 0.016
Right axial deviation 3 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 3 (0.0) 0.987
LVH by voltage criteria 249 (3.5) 0 (0.0) 3 (3.6) 13 (5.7) 233 (3.4) 0.285
Continuous variables are expressed as the meanSD, and categorical variables are presented as number (percentage). BP indicates blood pressure; BrS, Brugada-type ECG; LVH, left
ventricular hypertrophy; non-ST, Non–ST-segment elevation; STERP, atypical ST-Segment elevation in the right precordial leads.
*P<0.05, test for signiﬁcance against the non-ST group.
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multivariable HR 3.9, 95% CI 1.7–9.0), whereas those with
non–type 1 BrS had no excess risk of SCD (age- and sex-
adjusted HR 1.2, 95% CI 0.16–8.6; multivariable HR 1.1, 95%
CI 0.15–8.3) compared with those with non-ST (Table 2).
SCD in Participants With STERP
Results of further investigation into the ECG ﬁndings of the 7
participantswithSCDare shown in Table 3. Five of the 7 subjects
(71.4%)were aged in their 60s at death, and all weremale (100%).
P wave duration (52–120 ms), PR interval (140–200 ms), and
QRS duration (76–104 ms) were within normal limits in all
participants. SV1+RV5 in 3 of the 7 participants (42.9%) was
>3.5 mV. Corrected QT interval in 6 of the 7 participants (85.7%)
was within normal limits (<440 ms1/2).
Association of J Point Amplitude With SCD in
Participants Without BrS
Overall, 615 participants (8.6%) had J point amplitude ≥0.1 to
<0.2 mV (group B) and 6243 (87.0%) had J point amplitude
<0.1 mV (group C). Compared with the participants in group
C, the incidence of SCD in participants in groups A and B was
higher (age- and sex-adjusted HR 4.1 [95% CI 1.8–9.6] and 2.4
[95% CI 1.1–5.1], respectively; multivariable HR 3.9 [95% CI
1.7–9.0] and 2.5 [95% CI 1.2–5.3], respectively) (Table 4).
Discussion
Major Findings
We revealed an interesting ﬁnding in our large-scale and long-
term observational study: Participants with STERP had an
excess risk of SCD compared with those in the non-ST group.
Our study is the ﬁrst to ﬁnd that STERP is a distinct clinical
entity with a high risk of SCD in the middle-aged Japanese
general population.
Prevalence of BrS and Prognosis for Participants
With BrS
The prevalence of type1 BrS (0.1%) and non–type 1 BrS (1.2%)
in this cohort was compatible with that in previous studies:
0.0% to 0.2%5–10,12–14,19 for type 1 BrS and 0.0% to 6.0% for
non–type 1 BrS.4,5,7,9,10,13,14,20 In keeping with previous
reports,4,7,9,10,21,22 there was a male predominance among
participants with BrS. In the present study, no SCD among
participants with type 1 BrS and only 1 SCD among those with
Table 2. Unadjusted and Age- and Sex-Adjusted and Multivariable HRs of Type 1 BrS, Non–Type 1 BrS, and STERP Groups Against
the Non-ST Group
Type 1 BrS Non–Type 1 BrS STERP Non-ST
Person-years 202.3 2074.4 4816.8 177472.1
Number at risk 8 84 228 6858
Number of SCD 0 (0.0%) 1 (1.2%) 7 (3.1%) 50 (0.7%)
Age- and sex-adjusted HR (95% CI) — 1.2 (0.16–8.6) 4.1 (1.8–9.6) 1
Multivariable HR (95% CI) 1.1 (0.15–8.3) 3.9 (1.7–9.0) 1
Multivariable HR adjusted for age, sex, systolic blood pressure, antihypertensive medication use, smoking status, and diabetes mellitus. BrS indicates Brugada-type ECG; HR, hazard ratio;
non-ST, Non–ST-segment elevation; SCD, sudden cardiac death; STERP, atypical ST-segment elevation in the right precordial leads.
Table 3. Seven Cases of Sudden Cardiac Death With STERP
Case No. Age at Death (y) Sex P Wave Duration (ms) PR Interval (ms) QRS Duration (ms) SV1+RV5 (mm) QT/QTc (ms/ms
1/2)
1 61 Male 120 168 104 40 336/350
2 64 Male 52 172 72 32 292/326
3 65 Male 120 180 104 25 400/358
4 68 Male 80 200 80 30 360/389
5 63 Male 84 188 84 47 348/362
6 71 Male 96 140 80 30 480/451
7 80 Male 80 200 76 47 364/379
STERP indicates atypical ST-segment elevation in the right precordial leads.
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non–type 1 BrS was observed during the follow-up period,
which was consistent with previous community-based stud-
ies,6,8,9,12,14 except for the Atomic Heart Study.11 In that
study, the deﬁnition of type 1 BrS, which was characterized by
the coexistence of coved and saddleback morphology with J
point elevation ≥0.1 mV in V1 through V3, was different from
that in the second consensus report.3
Prognosis and Characteristics of Participants
With STERP
The arrhythmogenic potential of ER in the inferior leads was
highlighted recently by Ha€ıssaguerre et al.22 Nevertheless, in
the cohort studies examining early repolarization syndrome
(ERS), the right precordial leads were not included in the
analysis to avoid including BrS or arrhythmogenic right
ventricular cardiomyopathy. Kamakura et al extended the
deﬁnition of non–type 1 BrS and concluded that the long-term
prognosis of probands with non–type 1 BrS was similar to that
of probands with type 1 BrS in a hospital-based multicenter
study.23 Moreover, Kamakura et al investigated the signiﬁ-
cance of non–type 1 anterior ER in patients with idiopathic
ventricular ﬁbrillation and inferolateral ER in their hospital-
based study.15 They concluded that the coexistence of non–
type 1 anterior ER was a predictor of poor outcome in patients
with inferolateral ER and ventricular ﬁbrillation; however, these
studies included patients with non–type 1 BrS. Little is known
about what ST-T morphology, except for BrS in the right
precordial leads, is associated with malignant arrhythmia.
Consequently, we investigated ECGs with STERP without BrS
and analyzed the clinical characteristics and long-term prog-
nosis of participants with STERP. These participants had a
markedly elevated risk of SCD compared with those with non-
ST. To the best of our knowledge, this report is the ﬁrst to show
a signiﬁcantly higher risk of SCD in participants with STERP.
Clinical characteristics were as follows. First, participants
with STERP were predominantly male (94.7%) and were
signiﬁcantly younger than participants in the non-ST group,
which is the same as that with Brugada syndrome and
ERS.18,24,25 This suggests a particular young and male
background that relates to heredity, hormonal factors, or
autonomic nervous function. Haruta et al proposed a hypoth-
esis that testosterone may modulate cardiac mortality in
ERS.26 The plasma concentration of testosterone is higher in
men with BrS than in other age-matched men15 and was
reported to increase net outward current of the epicardium, to
aggravate the transmural voltage gradient between the
epicardium and endocardium, and to lead to the J point seen
in ERS and BrS.27 In our study, there was no signiﬁcant
difference in body mass index that would indicate an inﬂuence
by testosterone between the STERP and non-ST groups,
indicating that testosterone may not play a leading role in the
prognosis of participants with STERP even if it could inﬂuence
the J point amplitude. Junttila et al28 reported that testos-
terone levels were closely associated with not only lateral J
point elevation but also with a rapidly ascending ST-segment
after J point elevation, which Tikkanen et al29 reported as
being benign in 3 types of ST-segments (ascending, horizon-
tal, or descending.) The mechanism of the J point in the right
precordial leads associated with testosterone would be the
same as that in the inferior leads.
Second, in the large number of participants without BrS,
the higher amplitude of the J point in the right precordial leads
was signiﬁcantly associated with SCD incidence. A hospital-
based study with a small number of participants (n=85)
reported that the incidence of SCD of probands with non–type
1 BrS including ECGs with a J point amplitude ≥0.1 to
<0.2 mV was similarly as high as those with type 1 BrS.15 In
terms of J point amplitude, our result is identical to that of a
previous large-scale community-based study that investigated
the inferior leads and showed that J point elevation of at least
0.1 mV in the inferior leads was associated with a high risk of
cardiac death, and J point elevation of >0.2 mV in the inferior
leads had a higher risk of arrhythmia events and cardiac
death.25 Similarly, we focused on the right precordial leads in
this middle-aged Japanese general population without BrS and
revealed that the amplitude of the J point elevation in the right
precordial leads had some prognostic value, and there was a
higher risk of SCD among participants with a markedly
elevated J point (>0.2 mV) than among those with more
moderate elevation (≥0.1 mV).
Study Limitations
First, we did not systematically obtain data on the history of
syncope or the family history of SCD in our population-based
cohort study, which indicates that our cases of SCD could be
Table 4. Unadjusted, Age- and Sex-Adjusted, and
Multivariable HRs for SCD of STERP
Group A Group B Group C
Person-years 4816.8 8951.1 117210.7
Number at risk 228 615 6243
Number with SCD 7 (3.1%) 11 (1.8%) 39 (0.1%)
Age- and sex-
adjusted HR (95% CI)
4.1 (1.8–9.6) 2.4 (1.1–5.1) 1
Multivariable
HR (95% CI)
3.9 (1.7–9.0) 2.5 (1.2–5.3) 1
HRs are for group A (J point amplitude >0.2 mV) and group B (J point amplitude >0.1 to
<0.2 mV) versus group C (J point amplitude <0.1 mV). The multivariable HR is adjusted
for age, sex, systolic blood pressure, antihypertensive medication use, smoking status,
and diabetes mellitus. HR indicates hazard ratio; SCD, sudden cardiac death; STERP,
atypical ST-segment elevation in the right precordial leads.
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sporadic. For Brugada syndrome, however, if a substantial
number of SCD cases had not been sporadic, the benign
feature of BrS in our study would be strengthened.
Second, the statistical power was insufﬁcient for persons
aged <40 years, and generalization would be questionable
because almost no SCD was observed in this age group. It is
possible that ER in our participants had an identity different
from that in younger persons. Moreover, to exclude lethal
conditions other than arrhythmias that can be present in
participants aged >65 years, we limited participant age to 40
to 65 years. The mean age (51.8 years) at registration in the
present study was older than that in most of the previous
hospital- or community-based studies that analyzed partici-
pants diagnosed as having ERS or Brugada syndrome.15,25,27
Nevertheless, 90% of the SCDs were observed in partici-
pants aged >40 years.30 With participant age at registration
(40–64 years) and the >18-year follow-up period, we could
cover almost all possible age ranges during which a malignant
arrhythmia would occur.
Third, to exclude structural heart disease from this study,
we excluded only participants who were diagnosed as having
myocardial infarction at registration and/or whose ECG
displayed atrial ﬁbrillation without performing echocardiogra-
phy, cardiac catheterization, and electrophysiological study.
The study population might include patients with structural
heart disease, which also features ERS or BrS. Miyazaki et al
reported that J point elevation is typically observed in patients
with hypothermia, hypercalcemia, myocardial ischemia, and
brain injury31; however, these conditions were not commonly
found among the participants in routine health checkups.
Even a self-reporting system without evaluation by ECG or
echocardiography can be useful to exclude cardiac disease
from the baseline population.32
Fourth, we examined only standard ECGs with precordial
positions recorded from the fourth intercostal space in a
single examination and did not perform drug provocation
tests. A higher precordial position might have increased the
prevalence of type 1 BrS33; therefore, the prevalence of
spontaneous and drug-induced type 1 BrS may be underes-
timated.
Fifth, the J amplitude of ER and the type of BrS can
ﬂuctuate over time, especially immediately before ventricular
ﬁbrillation,27 which might cause us to underestimate the
prevalence of ER and BrS, respectively. Repetitive ECG
recordings are necessary to investigate the mode of ﬂuctu-
ation in ECGs with atypical J point elevation.
Sixth, the prevalence of type 1 BrS in this study is as rare
as that in previous studies, which revealed that almost no
SCD occurred in participants with type 1 BrS. In this study,
only 8 participants with type 1 BrS were found, and none of
them died. To increase statistical power, a much greater
number of participants would be needed.
Conclusion
STERP rather than BrS was associated with an elevated risk of
SCD in a middle-aged Japanese general population.
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